PSMAI cut-off value for mortality in men: 680.1 mm2/m2
Por um escritor misterioso
Descrição
EAU 2022: Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
The TBI SBP Sweet Spot – Is 130-180 mmHg the New Normotension? – JournalFeed
ASCO GU 2022: Predicting the Outcome of mCPRC Patients after Lu-177 PSMA Therapy Using Semi-Quantitative and Visual Criteria in Baseline PSMA PET: An International Multicenter Retrospective Study
Voluntary Medical Male Circumcision (VMMC)
SARCLISA® (isatuximab-irfc) ICARIA-MM Phase 3 Trial Results
PSMAI cut-off value for mortality in men: 680.1 mm2/m2
Reduced Acquisition Time per Bed Position for PET/MRI Using 68Ga-RM2 or 68Ga-PSMA-11 in Patients With Prostate Cancer: A Retrospective Analysis
PSMAI cut-off value for mortality in men: 680.1 mm2/m2
Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177- PSMA-617 radioligand therapy, BMC Urology
PDF) The association between psoas muscle area index and morbidity/mortality in laparoscopic gastric cancer surgery
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
Abstract 11678: ST2 Is A Biomarker Of Pediatric Pulmonary Arterial Hypertension Severity And Clinical Worsening
CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in NSCLC - (ILCN/WCLC)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
